Neonatal hypothyroidism increases adult Sertoli cell populations by extending Sertoli cell proliferation. Conversely, hyperthyroidism induces premature cessation of Sertoli cell proliferation and stimulates maturational events like seminiferous tubule canalization. Thyroid hormone receptors ␣1 and ␤1, which are commonly referred to as TR␣1 and TR␤1, respectively, are expressed in neonatal Sertoli cells. We determined the relative roles of TR␣1 and TR␤1 in the thyroid hormone effect on testicular development and Sertoli cell proliferation using Thra knockout (TR␣KO), Thrb knockout (TR␤KO), and wild-type (WT) mice. Triiodothyronine (T 3 ) treatment from birth until Postnatal Day 10 reduced Sertoli cell proliferation to minimal levels in WT and TR␤KO mice versus that in their untreated controls, whereas T 3 had a diminished effect on TR␣KO Sertoli cell proliferation. Seminiferous tubule patency and luminal diameter were increased in T 3 -treated WT and TR␤KO testes. In contrast, T 3 had no effect on these parameters in TR␣KO mice. In untreated adult TR␣KO mice, Sertoli cell number, testis weight, and daily sperm production were increased or trended toward an increase, but the increase in magnitude was smaller than that seen in WT mice following neonatal hypothyroidism. Conversely, in TR␤KO mice, Sertoli cell number, testis weight, and daily sperm production were similar to those in untreated WT mice. In addition, Sertoli cell number and testis weight in adult WT and TR␤KO mice showed comparable increases following hypothyroidism. Our results show that TR␣KO mice have testicular effects similar to those seen in WT mice following neonatal hypothyroidism and that TR␤KO mice, but not TR␣KO mice, have normal Sertoli cell responsiveness to T 3 . Thus, effects of exogenous manipulation of T 3 on neonatal Sertoli cell development are predominately mediated through TR␣1.
INTRODUCTION
During the past 15 yr, numerous laboratories have shown that triiodothyronine (T 3 ) plays a key role in Sertoli cell development [1] [2] [3] [4] and, ultimately, affects the establish- ment of adult Sertoli cell populations and the magnitude of adult sperm production. Triiodothyronine has a direct inhibitory effect on Sertoli cell proliferation and a concomitant stimulatory effect on Sertoli cell differentiation. For example, transient neonatal hypothyroidism in rodents extends the length of Sertoli cell proliferation, leading to significant increases in Sertoli cell number, daily sperm production (DSP), and testis weight [1, [4] [5] [6] [7] . Conversely, hyperthyroidism induced by exogenous T 3 injections results in a premature cessation of mitogenesis and precocious canalization of seminiferous tubules [8] .
Although the effects of T 3 on the testis initially were described in rodents [1, [4] [5] [6] [7] [8] , subsequent work has indicated that neonatal/juvenile hypothyroidism increases testis size in humans [9] , roosters [10] , and fish [11] . Similarly, high neonatal thyroid hormone levels in bulls resulted in decreased adult testis size and sperm production [12] . Clearly, the T 3 effect on the developing testis is a critical process in mammalian and even nonmammalian species.
Effects of T 3 on target organs are regulated by thyroid hormone receptors (TRs) that are nuclear ligand-modulated transcription factors encoded by two genes, Thra and Thrb. Both genes can be alternatively spliced, and nine peptide isoforms have been isolated. Three functional peptides have been identified: ␣1 (also known as THRA1) from Thra, and ␤1 and ␤2 (sometimes referred to as THRB1 and THRB2, respectively) from Thrb. The remaining six receptor isoforms lack portions of the DNA-binding and/or ligandbinding domains, and their functions remain unclear. Binding assays have shown that TR is expressed in developing testis [13, 14] , and we, along with others, have reported that TR␣1 mRNA and protein are abundant in the developing testis and, specifically, in Sertoli cells [15, 16] . Furthermore, both TR␣2 and TR␣3 (also known as Thra2 and Thra3, respectively) mRNA are expressed in Sertoli cells [15] [16] [17] . Both TR␣2 and TR␣3 do not mediate T 3 signaling, because neither isoform binds T 3 [18] . However, TR␣2 binds to thyroid hormone-responsive elements in the absence of ligand, and as a result, TR␣2 may be a constitutive antagonist in T 3 signaling capable of partially silencing T 3 -mediated gene expression [19] . Therefore, T 3 signaling through TR␣ within neonatal Sertoli cells, in previous studies as well as in the present experiments, is presumed to be through the TR␣1 isoform.
A sizeable amount of literature also indicates that TR␤1 could be involved in Sertoli cell development, although this area is controversial. Tagami et al. [20] reported expression of TR␤1 in developing rat testes, and the concentrations of TR␤1 in these testes were equivalent to the concentrations of TR␣1. These findings were corroborated by a recent report showing that TR␤1 mRNA is expressed in the testis of both juvenile and adult rats [21] . Neither of these studies, however, addressed the question of which cell type in the testis expressed TR␤1, but other work has indicated that TR␤1 mRNA is specifically expressed in the Sertoli cells of prepubertal rats [22, 23] . In addition, TR␤1 mRNA is expressed in Sertoli cells of developing boar testes [22] , and this initial finding, using a polymerase chain reaction methodology, has been confirmed by the recent report that TR␤1 immunostaining could be detected in the developing boar testis using an antibody that specifically recognized the 55-kDa TR␤1 and did not cross-react with TR␣1 [3] . In contrast, others have reported that they could not detect TR␤1 mRNA or protein in a series of studies involving both rat and human Sertoli cells [15, 17, 24] . Because TR␤2 has a restricted distribution in the nervous system, it is unlikely to be involved in Sertoli cell development. Therefore, all T 3 actions mediated through TR␤ within the testis are assumed to be mediated through TR␤1.
These data indicate that TR␣1 and/or TR␤1 could potentially mediate the effects of T 3 on Sertoli cells. Despite advances in our understanding of T 3 /TR signaling in Sertoli cells, the relative roles of TR␣1 and TR␤1 in Sertoli cell maturation from a mitogenic to nonmitogenic differentiating state during early postnatal life remain unresolved.
Transgenic mice lacking Thra or Thrb and, thus, all of either TR␣ or TR␤ isoforms, respectively, have been developed [25] [26] [27] . To our knowledge, testicular growth, histology, and other parameters have not been examined in either Thra or Thrb knockouts (referred to hereafter as TR␣KO and TR␤KO, respectively), but the fertility of both knockouts, as well as of the double-knockout males lacking both TR␣1 and all TR␤ isoforms [28] , suggests that testicular development and function must not be compromised significantly. In this report, we have used TR␣KO and TR␤KO mice to determine the relative roles of these receptors in mediating thyroid hormone effects on Sertoli cell and testicular development. Our results suggest that signaling through TR␣1 is the normal mechanism by which T 3 promotes normal Sertoli cell maturation.
MATERIALS AND METHODS

Animals and Treatments
Both TR␣KO and TR␤KO mice on a C57BL/6 background were generated by Dr. Jacques Samarut (Laboratoire de Biologie Moléculaire et Cellulaire de l'Ecole Normal Supérieure de Lyon, Lyon, France) and obtained through Dr. Roy Weiss (University of Chicago, Chicago, IL), whereas C57BL/6 wild-type (WT) mice were bred and maintained from our mouse colony as described previously [7] . Mice were housed at 25ЊC with 12L:12D photoperiod and were given water and a standard rodent diet ad libitum. All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Illinois and conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.
Determination of Adult Sertoli Cell Number, Testis Weight, and DSP Between 115 and 120 days of age, TR␣KO, TR␤KO, and WT male mice (n ϭ 7-14 per genotype) were given a lethal injection of ketamine, and one testis was excised for determination of testis weight and DSP as described previously [7] . The remaining testis was fixed by vascular perfusion using 10% neutral-buffered formalin, embedded in paraffin, sectioned (thickness, 4 m), and stained with hematoxylin/eosin for Sertoli cell enumeration. Total Sertoli cell number per testis was determined as described previously [6] .
Neonatal T 3 Treatment of TRKO Mice
Litters (n ϭ 4 per treatment per genotype) were assigned randomly to euthyroid or hyperthyroid groups. The T 3 (Sigma, St. Louis, MO) was dissolved in 0.025 N sodium hydroxide, then diluted in physiological saline. To make pups hyperthyroid, T 3 was administered by daily subcutaneous injections of 100 g/kg body weight in 10 l of vehicle [8] . On Postnatal Day 10 (day of birth ϭ Postnatal Day 0), male pups were killed for testes excision.
Determination of Sertoli Cell Proliferation
To determine Sertoli cell proliferation in T 3 -treated versus untreated KO and WT mice, one testis per animal from 10-day-old WT, TR␣KO, and TR␤KO mice (n ϭ 4-8 per treatment) were fixed for 1 wk in 10% neutral-buffered formalin at room temperature before dehydration and paraffin embedding. Tissues were serially sectioned (thickness, 4 m), then deparaffinized and rehydrated. Slides were placed in boiling 10 mM sodium citrate buffer (pH 6.0) for 10 min, then allowed to cool to room temperature to facilitate antigen unmasking [29] . Endogenous peroxidase activity was quenched by incubating sections in 0.3% H 2 O 2 for 30 min. Sertoli cells were identified through immunodetection of Wilms tumor protein (WT1) using a rabbit polyclonal immunoglobulin (Ig) G to human WT1 (Santa Cruz Biotechnology, Santa Cruz, CA). In the testis, WT1 is a constitutively expressed transcription factor found only in Sertoli cells and, thus, functions as a cell-specific marker [30] . On an adjacent serial section, cell proliferation was detected using mouse anti-human monoclonal IgG to human Ki-67 (BD Transduction Laboratories, Lexington, KY). Binding of primary antibody was localized using a horseradish peroxidaseVectastain ABC Kit (Vector Laboratories, Burlingame, CA) for each species and a DAB Substrate Kit (Vector) according to the supplier's instructions. Negative-control tissue sections were processed with normal goat serum instead of primary antibody to determine nonspecific staining. Following immunostaining, sections were counterstained with Hematoxylin QS (Vector). The number of proliferating Sertoli cells was determined by Ki-67 staining, which is indicative of cell proliferation [31] , in 500 Sertoli cells identified by positive WT1 staining.
Determination of Sertoli Cell Maturation Using p27
Kip1 ,
Seminiferous Tubule Patency, and Luminal Diameter as Markers
Progression through the cell cycle is regulated, in part, by the kinase activity created from complexes formed between cyclins D and E (also known as CCND1 and CCNE1, respectively) and cyclin-dependent kinase (CDK)-4, CDK6, and CDK2. The CDK inhibitors, such as p27 Kip1 (also known as CDKN1B), inhibit this kinase activity and, thus, play a critical role in transition through the G 1 checkpoint. Expression of p27 Kip1 protein is highest in cells that have withdrawn from the cell cycle compared to cells in G 1 even though they have equivalent p27 Kip1 mRNA levels [32] . In both rapidly proliferating neonatal Sertoli cells [33] and Sertoli cell tumors [34] , p27 Kip1 expression is low. Cessation of Sertoli cell proliferation coincides with cellular maturation, and nonproliferating Sertoli cells express high levels of p27 Kip1 [33, 35, 36] . Therefore, intensity of p27 expression serves as a qualitative marker of Sertoli cell maturation. To assess Sertoli cell maturation, immunostaining for p27 Kip1 was performed in T 3 -treated and control testes from 10-day-old TR␣KO, TR␤KO, and WT pups (n ϭ 4-8 per treatment) as described previously [35] .
To examine Sertoli cell maturation and secretory activity further, seminiferous tubule luminal patency and diameter were evaluated. A minimum of 500 cross-sectioned seminiferous tubules were evaluated in T 3 -treated and control testes from 10-day-old TR␣KO, TR␤KO, and WT pups, and the percentage of patent lumens was calculated. Seminiferous tubule luminal diameter was measured using ImageJ software (NIH, Bethesda, MD) in a minimum of 80 cross-sectioned tubules per treatment group and genotype.
Effects of Neonatal Hypothyroidism on Sertoli Cells in TR␤KO Mice
Initial results demonstrated that the effects of T 3 were mediated through TR␣1. To corroborate these results and determine if TR␤1 plays a critical role in establishing the increased Sertoli cell population following hypothyroidism, TR␤KO mice were subjected to transient neonatal hypothyroidism. The TR␤KO litters (n ϭ 2 per treatment) were randomly assigned to euthyroid and hypothyroid groups. Pups were made hypothyroid by the addition of 0.1% 6-propyl-2-thiouracil (PTU) to the dam's drinking water from birth until Postpartum Day 25 as described previously [7] . Drinking water for the euthyroid litters was untreated. On Postnatal Day 26, pups were weaned and returned to tap water to allow recovery to euthyroidism. Sertoli cell number was calculated in PTU-treated and control TR␤KO mice between Postnatal Days 58 and 60 as described
FIG. 1. Effects of loss of TR on Sertoli cell number (A), testis weight (B)
, and DSP (C) in testes from 4-mo-old WT, TR␣KO, and TR␤KO mice. Despite a strong trend for increased Sertoli cell number and DSP, loss of TR␣ did not result in significant differences from WT mice. In contrast, testis weights were significantly increased in TR␣KO compared to WT mice. Loss of TR␤ did not produce significant changes in Sertoli cell number, testis weight, or DSP compared to WT mice. Data are shown as the mean Ϯ SEM (n ϭ 7-14 testes/genotype). Values that do not share a common superscript are significantly different.
FIG. 2.
Sertoli cell proliferation in untreated and T 3 -treated neonatal WT, TR␣KO, and TR␤KO mice. Mice were treated with vehicle or T 3 (100 g/ kg body weight) from birth to Postnatal Day 10, and testes were evaluated for Sertoli cell proliferation. Sertoli cell proliferation was similar in untreated WT and TR␣KO mice but significantly reduced in untreated TR␤KO mice. Treatment with T 3 significantly inhibited Sertoli cell proliferation in neonatal WT and TR␤KO mice compared to their untreated controls of the same genotype. In contrast, T 3 -treated TR␣KO mice did not show significantly reduced proliferation compared to untreated TR␣KO mice. Data are shown as the mean Ϯ SEM (n ϭ 4-11 testes/ genotype/treatment). Values that do not share a common superscript are significantly different.
above. Initially, we also planned to determine the effects of transient neonatal hypothyroidism on Sertoli cells in TR␣KO mice. However, this did not prove to be feasible in TR␣KO mice because of impaired maternal behavior and consequent high neonatal mortality resulting from any treatment of the dam.
Statistical Analysis
All data are presented as the mean Ϯ SEM. Comparisons of means for Sertoli cell number, testis weight, and DSP in WT, TR␣KO, and TR␤KO mice were analyzed using one-way ANOVA followed by the Tukey honestly significant difference (HSD) multiple-comparison procedure. Seminiferous tubule patency data were coded for open or closed lumen before performing contrast analyses [37, 38] to determine differences. Categorical variables were coded in model before seminiferous tubule luminal diameter and square root-transformed Sertoli cell proliferation data were analyzed using one-way ANOVA followed by Tukey HSD multiple comparisons. Differences in testis weights and Sertoli cell number between control and PTU-treated TR␤KO mice were analyzed by Student t-test. All statistical models initially included blocking for litter. However, litter was removed from models when significance was not reached. Differences were considered to be significant at P Ͻ 0.05.
RESULTS
Effects of Loss of TR␣ or TR␤ on Adult Sertoli Cell
Number, Testis Weight, and DSP Despite a trend (P ϭ 0.08) toward increased Sertoli cell numbers in TR␣KO mice, adult Sertoli cell numbers in 120-day-old TR␣KO mice (4.1 Ϯ 0.4 ϫ 10 6 ) did not significantly differ from those in WT controls (3.2 Ϯ 0.4 ϫ 10 6 ) (Fig. 1A) . Although not significantly different (P ϭ 0.26), Sertoli cell number in TR␤KO mice (2.7 Ϯ 0.2 ϫ 10 6 ) was lower than that in WT controls. Testis weights showed significant 20% increases in TR␣KO mice compared to WT mice (Fig. 1B) , whereas TR␤KO testes were similar to WT testes. However, body weights of TR␣KO (31.7 Ϯ 0.9 g) and TR␤KO (30.7 Ϯ 1.3 g) mice did not differ (P ϭ 0.27) from those of WT mice (33.2 Ϯ 1.0 g). Neither TR␣KO nor TR␤KO DSP values differed from WT values (Fig. 1C) , although the TR␣KO values again showed a trend toward an increase compared to the WT values (P ϭ 0.07).
Inhibition of Sertoli Cell Proliferation in TR␣KO and TR␤KO Mice Following T 3 Injections
Sertoli cell proliferation, as determined by labeling index, was 3.2% in 10-day-old euthyroid WT mice, which is consistent with previously reported values [4, 7, 8] . In 10-day-old untreated WT mice, Sertoli cell proliferation was eightfold greater than that in mice treated from birth with T 3 (3.2% vs. 0.4% respectively) (Fig. 2) . Similarly, Sertoli cell proliferation was sixfold greater in untreated TR␤KO mice compared to that in T 3 -treated TR␤KO mice (0.6% vs. 0.1%, respectively) (Fig. 2) . However, the number of Sertoli cells proliferating in 10-day-old untreated TR␤KO mice was 20% of that in untreated WT mice (WT, 3.2%; TR␤KO, 0.6%). Sertoli cell proliferation in untreated 10-day postnatal TR␣KO mice was 3.2%, which is consistent with Sertoli cell proliferation in age-matched untreated WT
THYROID HORMONE RECEPTORS IN SERTOLI CELLS
FIG. 3. Effects of T 3 on expression of p27
Kip1 in Sertoli cells from 10-day-old WT and TR␣KO mice. Either T 3 or vehicle was given to neonatal mice as described in Figure 2 . Immunohistochemical detection of p27 Kip1 protein is indicated by brown coloration, and samples were counterstained with hematoxylin (blue). All samples were stained under identical conditions in the same staining run to allow direct comparisons. A) Sertoli cells of euthyroid WT mice showed heterogeneous nuclear staining for p27 Kip1 , with some cells showing more intense brown coloration (black arrow) indicative of greater maturation and withdrawal from the cell cycle. Other Sertoli cells showed minimal p27
Kip1 staining (white arrow), indicating that they remain in the cell cycle. Note that only Sertoli cells stain for p27 Kip1 , with all germ cells showing only blue counterstain. B) Sertoli cells of T 3 -treated WT mice had heavily concentrated, darkbrown nuclear staining (arrowheads) indicative of high p27
Kip1 protein levels and cell-cycle arrest. C and D) Sertoli cells of euthyroid (C) and T 3 -treated (D) TR␣KO mice displayed a pattern of heterogeneous expression of p27 Kip1 (black and white arrows), indicating that T 3 did not alter p27
Kip1 expression and that T 3 effects on Sertoli cell maturation are mediated through TR␣1. Bars ϭ 25 m.
mice. In contrast to WT and TR␤KO mice, T 3 -treated TR␣KO mice still exhibited significant proliferation following T 3 treatment. Sertoli cell proliferation in T 3 -treated TR␣KO mice showed a modest reduction that did not reach significance (P ϭ 0.06) compared to that in untreated TR␣KO controls, and this response was far less than that seen in WT and TR␤KO mice in response to T 3 . This resulted in a labeling index in the T 3 -treated TR␣KO mice (2.0%) that was far greater than that in the T 3 -treated WT and TR␤KO mice, which had Sertoli cell proliferation of only 0.4% and 0.1%, respectively.
T 3 Increases Sertoli Cell p27
Kip1 Expression in WT but not TR␣KO Mice Expression of p27 Kip1 in Sertoli cells was compared in untreated and T 3 -treated, 10-day-old WT, TR␣KO, and TR␤KO mice. In all seminiferous tubule sections analyzed, immunodetection of p27 Kip1 expression was limited to Sertoli cells, which is consistent with previous reports [33] . Sertoli cells from untreated WT mice displayed heterogeneity in nuclear p27 Kip1 protein expression (Fig. 3A) , with the intensity of staining ranging from light to moderately heavy. In contrast, T 3 -treated WT mice had consistently heavy nuclear p27 Kip1 expression in all Sertoli cells (Fig.  3B) . Untreated TR␣KO mice also showed heterogeneity in Sertoli cell p27 Kip1 expression, with a range of staining intensity similar to that in untreated WT mice (Fig. 3C) . Although most nuclear staining of p27 Kip1 in untreated TR␣KO Sertoli cells was light to moderately heavy, numerous Sertoli cells had minimal p27 Kip1 expression. Significantly, T 3 did not increase p27 Kip1 expression in TR␣KO Sertoli cells (Fig. 3D ) compared to that in untreated TR␣KO mice, which is in contrast to the marked increases seen in T 3 -treated WT Sertoli cells compared to those in untreated WT Sertoli cells. Instead, p27 Kip1 expression in T 3 -treated TR␣KO Sertoli cells remained heterogeneous and was similar to that in both untreated WT and TR␣KO mice. Because of the already low percentage of Sertoli cells proliferating in 10-day-old untreated TR␤KO mice, p27 Kip1 expression was heavy (data not shown). Therefore, comparison of p27 Kip1 expression in untreated and T 3 -treated TR␤KO mice was not performed.
T 3 Does Not Increase Seminiferous Tubule Patency or Luminal Diameter in TR␣KO mice
During the early postnatal period, when Sertoli cell proliferation declines and then finally ceases, the solid seminiferous cords have not yet canalized to form the seminiferous tubules. Significant seminiferous tubule canalization and lumen formation normally begins during the latter part of the second postnatal week of life in rodents as a result of seminiferous fluid production by maturing Sertoli cells [8, 39] . Therefore, luminal patency and diameter are indicators of the onset and magnitude, respectively, of adluminal fluid production by maturing Sertoli cells. Consistent with these previous results, the percentages of seminiferous tubules with patent lumens on Postnatal Day 10 were similarly low in untreated WT, TR␣KO, and TR␤KO mice (Figs. 4 and 5A) . However, T 3 treatment starting at birth resulted in 19-and 12-fold increases in tubule patency in 10-day-old WT and TR␤KO mice, respectively, compared to that in their untreated controls. In contrast, seminiferous tubules in TR␣KO mice did not show increased luminal canalization in response to T 3 .
Luminal diameters of seminiferous tubules in 10-day-old untreated TR␤KO mice were comparable to those in control WT mice, whereas luminal diameters in TR␣KO mice were smaller than those in WT controls (Fig. 5B) . As expected, T 3 increased seminiferous tubule luminal diameter by sevenfold in WT testes compared to those from untreated WT FIG. 4 . Ability of T 3 treatment to induce precocious seminiferous tubule canalization in 10-day-old WT, TR␣KO, and TR␤KO mice. Either T 3 or vehicle was given to neonatal mice as described in Figure  2 . Seminiferous tubules in WT controls (A) showed minimal canalization on Postnatal Day 10. However, T 3 treatment of WT mice (B) resulted in significant increases in the number of patent tubules. Although seminiferous tubule canalization in control TR␣KO mice (C) was similar to that in control WT mice, loss of TR␣ precluded seminiferous tubule canalization induced by T 3 treatment (D). Canalization of seminiferous tubules in control (E) or T 3 -treated (F) TR␤KO mice resembled that in the control and T 3 -treated WT mice, respectively, indicating that the T 3 effects on canalization did not require TR␤. Bars ϭ 50 m.
mice. Likewise, TR␤KO mice exhibited eightfold increases in tubule diameter after T 3 treatment compared to control TR␤KO testes (Figs. 4 and 5B). In striking contrast to WT and TR␤KO mice, mean luminal diameter in TR␣KO mice was not significantly increased by T 3 treatment. This resulted in luminal diameters of patent seminiferous tubules in T 3 -treated TR␣KO mice that were 90% smaller than the patent tubules in either T 3 -treated WT or TR␤KO tubules.
TR␤KO Mice Respond Normally to Transient Neonatal Hypothyroidism
Consistent with previous reports [7] , PTU treatment increased testis weights (data not shown) and Sertoli cell number (Fig. 6 ) in 60-day-old WT mice. After recovery from transient neonatal hypothyroidism, testis weights in 60-day-old TR␤KO mice (111 Ϯ 2 mg) were 38% greater than those in untreated TR␤KO controls (80 Ϯ 2 mg). Similarly, PTU treatment resulted in a significant 31% increase in adult Sertoli cells in TR␤KO mice following transient neonatal hypothyroidism (3.8 Ϯ 0.3 ϫ 10 6 ) compared to that in untreated TR␤KO mice (2.9 Ϯ 0.2 ϫ 10 6 ) (Fig. 6) . Critically, the increase in Sertoli cell number in TR␤KO mice after PTU treatment was similar to that observed in PTU-treated WT mice (Fig. 6) .
DISCUSSION
Expression of TR in rat and human testes is maximal during late fetal and early neonatal life, when Sertoli cell proliferation is high; TR levels subsequently decline as Sertoli cell proliferation ceases [13, 17, 23, 30] . In rats, serum thyroid hormone concentrations rise markedly during early postnatal life [40] , a time when expression of both TR␣1 and TR␤1 in Sertoli cells has been demonstrated [3, 13, 15, 17, 23, 24, 41, 42] , suggesting that either or both may play a role in regulation of Sertoli cell proliferation. In the present study, we used knockout mice lacking either ␣ or ␤ isoforms of TR to determine if the inhibition of proliferation and stimulation of maturation in Sertoli cells by T 3 occurs through TR␣1 and/or TR␤1.
Our results show that TR␣1, rather then TR␤1, is critical for T 3 actions on Sertoli cell development in mice. Luminal canalization in seminiferous cords, which begins during the second week of postnatal life and is stimulated by T 3 , is a useful indicator of T 3 effects on Sertoli cells [2, 8, 39, 43] . Seminiferous tubule patency was relatively low in untreated mice of all genotypes at 10 days of age but was significantly greater in TR␤KO than in TR␣KO mice, suggesting that TR␣1 was critical for luminal canalization. Hyperthyroidism promoted Sertoli cell maturation and seminiferous tubule canalization in WT mice, as shown by marked increases in luminal patency and diameter, respectively, compared to euthyroid controls, which is consistent with previous findings [8] . Treatment with T 3 resulted in a similar response in TR␤KO mice, with comparable increases in luminal patency and diameter. In contrast, T 3 treatment was unable to increase seminiferous tubule canalization or diameter in TR␣KO mice. The inability of T 3 to induce seminiferous tubule luminal opening in TR␣KO mice, but not in TR␤KO mice, illustrates that TR␣1 is necessary for mediating the primary effects of T 3 on Sertoli cell maturation.
Despite their overall initial decreases in Sertoli cell proliferation, TR␤KO mice showed further reductions in Sertoli cell proliferation following neonatal hyperthyroidism, indicating that the absence of TR␤1 does not preclude inhibitory T 3 effects on Sertoli cell proliferation. In contrast to that in both WT and TR␤KO mice, Sertoli cell proliferation in TR␣KO mice was not significantly reduced following T 3 treatment. In addition, p27 Kip1 expression in T 3 -treated TR␣KO mice remained light to moderately heavy in intensity, similar to that in untreated WT and TR␣KO mice and contrasting with the heavy p27 Kip1 nuclear staining in Sertoli cells from T 3 -treated WT mice, suggesting that TR␣1 is necessary for the inhibition of Sertoli cell proliferation and maturation by T 3 . Moreover, if TR␤1 was the primary mediator of the T 3 effect on Sertoli cell proliferation, then TR␣KO mice should have shown a hyperresponsivity to T 3 treatment because of the loss of constitutive silencing by TR␣2 [19] .
The trend toward a diminished Sertoli cell response in T 3 -treated TR␣KO mice may be more reflective of secondary endocrine effects of hyperthyroidism than that of direct effects on Sertoli cells. Recent evidence has shown that hyperthyroidism decreases FSH and insulin-like growth factor (IGF)-I in males [44] . Both FSH and IGF-I increase proliferation in neonatal Sertoli cells [45, 46] , a time when FSH-receptor expression normally is rising [47] , and knockout mice lacking either FSH or IGF-I have decreased numbers of Sertoli cells and smaller testes [48] [49] [50] , illustrating that these hormones are critical mitogens in neonatal Sertoli cells. Therefore, a reduction in FSH and/or IGF-I as a result of T 3 treatment may be involved in the modest decrease in Sertoli cell proliferation in TR␣KO mice even in the absence of direct T 3 effects on Sertoli cell proliferation.
The inability of T 3 to produce precocious luminal canalization in the absence of TR␣1 also is consistent with the hypothesis that reduced Sertoli cell proliferation in T 3 -treated TR␣KO mice results from secondary effects, such as reduced FSH and IGF-I, rather than from signaling through TR␤1. Taken together, the luminal canalization and Sertoli cell proliferation data support the hypothesis that TR␣1 plays the critical role in neonatal Sertoli cell proliferation and maturation.
The TR␤1 is important for thyroid hormone negative feedback, and TR␤KO mice have elevated TSH and mild hyperthyroidism [25] . Therefore, the reduction in Sertoli cell proliferation in 10-day-old untreated TR␤KO (0.6%) compared to WT (3.2%) mice may reflect exposure to elevated T 3 levels during neonatal life. This hypothesis is supported by the comparable Sertoli cell proliferation observed between TR␤KO and WT mice at Postnatal Day 5 (data not shown), which became significantly reduced in TR␤KO compared to WT mice by 10 days. Therefore, the fact that adult TR␤KO and WT Sertoli cell populations do not differ at 120 days of age may be a result of the similar percentages of proliferating Sertoli cells at Postnatal Day 5, when a higher percentage of Sertoli cells are in the cell cycle. However, other possibilities not explored in the present study include an extended period of low Sertoli cell proliferation or a reduction in apoptosis [51] [52] [53] in TR␤KO compared to WT mice. Moreover, the decreased proliferation of TR␤KO Sertoli cells, most likely in response to increased endogenous thyroid hormone, again suggests that TR␤1 is not the receptor responsible for inhibitory effects of T 3 on Sertoli cell proliferation. This is consistent with the conclusion from data indicating that T 3 treatment of TR␤KO mice produced a further reduction in Sertoli cell proliferation that was qualitatively similar to that in T 3 -treated WT mice.
The conclusion that TR␣1 mediates T 3 effects on Sertoli cells obtained from the hyperthyroidism experiments can be examined directly by determining whether hypothyroidism can increase Sertoli cell proliferation normally in the absence of TR␤1. Our data indicate that TR␤1 is not necessary for increases in Sertoli cell populations after transient neonatal hypothyroidism, based on similar increases in Sertoli cell number and testis weight in adult WT and TR␤KO mice following neonatal PTU treatment. These data emphasize that hypothyroidism effects on Sertoli cells occur normally in TR␤KO mice and that T 3 regulates Sertoli cell proliferation through TR␣1 rather than TR␤1. Finally, treating TR␣KO litters with PTU could show definitively that the presence of TR␤1 is not sufficient to allow increases in Sertoli cell number induced by neonatal hypothyroidism. However, this complementary experiment could not be conducted because of difficulties in establishing pregnancies and high neonatal mortality in these mice, which was exacerbated when pups and, especially, dams were subjected to any treatment.
If TR␣1 is necessary for T 3 effects on Sertoli cells, then loss of TR␣1 in the TR␣KO mice should induce phenotypic changes comparable to those seen with hypothyroidism. Sertoli cell number, DSP, and subsequent testis weights show increases of approximately 40% following recovery from transient neonatal hypothyroidism [7] . Similarly, TR␣KO mice had 10-30% increases in adult Sertoli cell number, testis weight, and DSP compared to WT mice, although some of these changes did not achieve statistical significance. Critically, the increases in TR␣KO testis weights were not allometric, because body weights were similar to those of WT controls. Although the TR␣KO mice do not totally recapitulate the effects of hypothyroidism on Sertoli cell number, testis weight, or DSP, a strong trend exists toward increases in these parameters that also are increased by neonatal hypothyroidism. These findings are consistent with, and further confirm, the idea of TR␣1 as the predominate receptor isoform for T 3 effects in neonatal Sertoli cells.
